Updating results

7351 results

Sort: Relevance | Date

Digital and mobile interventions could support regular health services in helping people stop smoking and reduce their risk of obesity, says NICE

Health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developing chronic conditions.

News Published January 2020 Last updated January 2020

Preterm labour and birth

Everything NICE has said on the care of women in or at risk of preterm labour or having a planned preterm birth in an interactive flowchart

NICE Pathway Published November 2015 Last updated January 2020

Thyroid disease

Everything NICE has said on thyroid disease in children, young people and adults in an interactive flowchart

NICE Pathway Published November 2019 Last updated January 2020

Cancer Drugs Fund

Everything you need to know about the Cancer Drugs Fund (CDF) and the drugs we appraise.

Published January 2020 Last updated January 2020

Public Board meetings

View board meeting minutes and agendas and papers

Published January 2020 Last updated January 2020

Medicines and prescribing

Guidance, advice and support for delivering quality, safety and efficiency in the use of medicines

Published January 2020 Last updated January 2020

Changes we're making to health technology evaluation

On this page: What changes are we making? Get involved Who else is involved? Timeline Why we're making these changes Improvements we

Published January 2020 Last updated January 2020

Endorsement

Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.

Published January 2020 Last updated January 2020

Implementing Clinical Support for Informal Carers

Shared learning Published January 2020

Privacy notice

How we collect and use your personal information, and your rights under data protection legislation

Published January 2020 Last updated January 2020

Senior Management Team

Biographies of the NICE senior management team and minutes of their meetings

Published January 2020 Last updated January 2020

Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues (IPG666)

Evidence-based recommendations on reducing the risk of Creutzfeldt–Jakob disease (CJD) transmission from surgical instruments used for interventional procedures

Interventional procedures guidance Published January 2020

Care matters – Working together to get support right for adult carers

Dame Philippa Russell, Vice-President of Carers UK and Topic Adviser for the NICE guideline on Supporting Adult Carers

News Published January 2020 Last updated January 2020

Elsevier

Provider name: Elsevier Lot details Lot 1 Electronic Journals, Electronic Books, Databases, Aggregated Evidence Resource Summaries, Point

Published January 2020 Last updated January 2020

Jobs

Jobs at NICE. Includes current vacancies, roles, location and salary information.

Published January 2020 Last updated January 2020

European Early Dialogues

Designed for developers of medicinal products and other similarly regulated technologies. Receive advice from NICE, the European Medicines Agency...

Published January 2020 Last updated January 2020

Supporting adult carers (NG150)

This guideline covers support for adults (aged 18 and over) who provide unpaid care for anyone aged 16 or over with health or social care needs. It aims to improve the lives of carers by helping health and social care practitioners identify people who are caring for someone and give them the right information and support. It covers carers’ assessments, practical, emotional and social support and training, and support for carers providing end of life care.

NICE guideline Published January 2020

Accelerated Access Collaborative (AAC)

The Accelerated Access Collaborative is a fast-track route into the NHS for “breakthrough” medicines and technologies

Published January 2020 Last updated January 2020

SAGE

Provider name: SAGE Lot details Lot 2 - Print journals, Electronic journals Provider helpdesk Customer account manager:

Published January 2020 Last updated January 2020

Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer (TA621)

Evidence-based recommendations on osimertinib (Tagrisso) for untreated locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (NSCLC)

Technology appraisal guidance Published January 2020

Who we are

Where you can find more information about how we operate

Published January 2020 Last updated January 2020

Dramatherapy group for adults living with psychosis

Shared learning Published January 2020

Lung cancer

Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

NICE Pathway Published March 2012 Last updated January 2020

Prevention and control of healthcare-associated infections

Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart

NICE Pathway Published March 2012 Last updated January 2020

Supporting adult carers

Everything NICE has said on supporting adults carers in an interactive flowchart

NICE Pathway Published January 2020

Highly Specialised Technologies Evaluation Committee

NICE recommendations on the use of highly specialised technologies are made by an independent advisory committee called the Highly Specialised...

Published January 2020 Last updated January 2020

NICE Evidence Services issues

The information below provides a summary of known issues and upcoming changes related to NICE Evidence Services. This information will be updated...

Published January 2020 Last updated January 2020

Healthy Knee Education Group

Shared learning Published January 2020

Ambulatory Acute Foot Service - Royal Free London NHS FT

Shared learning Published January 2020

Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)

Evidence-based recommendations on Virtual Touch Quantification for diagnosing and monitoring liver fibrosis in chronic Hepatitis B and C

Medical technologies guidance Published September 2015 Last updated January 2020

NICE encourages further data collection on 'game changing' histology independent cancer drugs

Larotrectinib (also called Vitrakvi and made by Bayer), a new treatment for a range of cancers, can’t be recommended for use in the NHS because at its current price, it doesn’t have the potential to be cost-effective.

News Published January 2020 Last updated January 2020

Make use of community pharmacists' skills, says NICE

Community pharmacy teams have the potential to play a greater role in health promotion and prevention says NICE, in a new draft quality standard.

News Published January 2020 Last updated January 2020

Self-limiting respiratory tract and ear infections – antibiotic prescribing

Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart

NICE Pathway Published August 2012 Last updated January 2020

Hepatitis B (chronic)

Everything NICE has said on diagnosing and managing chronic hepatitis B in children, young people and adults in an interactive flowchart

NICE Pathway Published June 2013 Last updated January 2020

Pneumonia

Everything NICE has said on diagnosing and managing community- and hospital-acquired pneumonia in an interactive flowchart

NICE Pathway Published December 2014 Last updated January 2020

Breast cancer patients to have further NICE-approved drug combination option on Cancer Drugs Fund

Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in final guidance published today (15 January 2020).

News Published January 2020 Last updated January 2020

Antimicrobial stewardship

Everything NICE has said on effective antimicrobial medicine use and preventing the spread of resistant microbes in an interactive flowchart

NICE Pathway Published August 2015 Last updated January 2020

Help implement NICE guidance

Join our panel to give your expert advice on tools and resources developed to support NICE guidance.

Published January 2020 Last updated January 2020

Journals and databases

Quick access to reliable information for health and social care professionals. Search HDAS, and other journals and databases.

Published January 2020 Last updated January 2020

Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal) (TA618)

NICE is unable to make a recommendation about the use in the NHS of atezolizumab (Tecentriq) with carboplatin and nab-paclitaxel for untreated advanced NSCLC

Technology appraisal guidance Published January 2020

Increasing use of health and social care data in guidance development

We're aiming to increase and extend the use of data in the development and evaluation of our guidance. Data sources could include: electronic health

Published January 2020 Last updated January 2020

Accreditation decisions

NICE accreditation decisions

Published January 2020 Last updated January 2020

Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer (TA619)

Evidence-based recommendations on palbociclib (Ibrance) with fulvestrant for hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

Technology appraisal guidance Published January 2020

Olaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer (TA620)

Evidence-based recommendations on olaparib (Lynparza) for relapsed platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer in adults with a

Technology appraisal guidance Published January 2020